These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15351386)

  • 1. Cocaine pharmacology and current pharmacotherapies for its abuse.
    Carrera MR; Meijler MM; Janda KD
    Bioorg Med Chem; 2004 Oct; 12(19):5019-30. PubMed ID: 15351386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positional linker effects in haptens for cocaine immunopharmacotherapy.
    Ino A; Dickerson TJ; Janda KD
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4280-3. PubMed ID: 17531484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapies for treatment of cocaine abuse: preclinical aspects.
    Carroll FI; Howell LL; Kuhar MJ
    J Med Chem; 1999 Jul; 42(15):2721-36. PubMed ID: 10425082
    [No Abstract]   [Full Text] [Related]  

  • 4. Fluorescent cocaine probes: a tool for the selection and engineering of therapeutic antibodies.
    Meijler MM; Kaufmann GF; Qi L; Mee JM; Coyle AR; Moss JA; Wirsching P; Matsushita M; Janda KD
    J Am Chem Soc; 2005 Mar; 127(8):2477-84. PubMed ID: 15725002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the reinforcing effects of memantine in cocaine-dependent humans.
    Vosburg SK; Hart CL; Haney M; Foltin RW
    Drug Alcohol Depend; 2005 Aug; 79(2):257-60. PubMed ID: 16002035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics of dopamine and its contribution to cocaine addiction.
    Haile CN; Kosten TR; Kosten TA
    Behav Genet; 2007 Jan; 37(1):119-45. PubMed ID: 17063402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of cocaine abuse and dependence.
    Mendelson JH; Mello NK
    N Engl J Med; 1996 Apr; 334(15):965-72. PubMed ID: 8596599
    [No Abstract]   [Full Text] [Related]  

  • 8. A shot against cocaine addiction.
    Lab Anim (NY); 2001 Apr; 30(4):12-3. PubMed ID: 11385738
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of the sigma1 receptor in the appetitive effects of cocaine.
    Maurice T; Romieu P
    Pharmacopsychiatry; 2004 Nov; 37 Suppl 3():S198-207. PubMed ID: 15547786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticocaine catalytic antibodies have no affinity for RTI compounds: implications for treatment.
    Kuhar MJ; Carroll FI; Bharat N; Landry DW
    Synapse; 2001 Aug; 41(2):176-8. PubMed ID: 11400184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances for the treatment of cocaine abuse: central nervous system immunopharmacotherapy.
    Dickerson TJ; Janda KD
    AAPS J; 2005 Oct; 7(3):E579-86. PubMed ID: 16353936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging pharmacological strategies in the fight against cocaine addiction.
    Sofuoglu M; Kosten TR
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):91-8. PubMed ID: 16503828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion.
    Leyton M; Casey KF; Delaney JS; Kolivakis T; Benkelfat C
    Behav Neurosci; 2005 Dec; 119(6):1619-27. PubMed ID: 16420164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor and its intracellular signaling pathways in cocaine addiction.
    Corominas M; Roncero C; Ribases M; Castells X; Casas M
    Neuropsychobiology; 2007; 55(1):2-13. PubMed ID: 17556847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction.
    Roberts DC
    Physiol Behav; 2005 Sep; 86(1-2):18-20. PubMed ID: 16061264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D(3) receptor partial agonist in animal models of cocaine abuse.
    Gyertyán I; Kiss B; Gál K; Laszlovszky I; Horváth A; Gémesi LI; Sághy K; Pásztor G; Zájer M; Kapás M; Csongor EA; Domány G; Tihanyi K; Szombathelyi Z
    J Pharmacol Exp Ther; 2007 Mar; 320(3):1268-78. PubMed ID: 17170312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a therapeutic vaccine for the treatment of cocaine addiction.
    Fox BS
    Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats.
    Belin D; Balado E; Piazza PV; Deroche-Gamonet V
    Biol Psychiatry; 2009 May; 65(10):863-8. PubMed ID: 18639867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical manifestations of cocaine abuse].
    Quaglio G; Lugoboni F; Pajusco B; Fornasiero A; Mezzelani P; Lechi A
    Ann Ital Med Int; 2004; 19(4):291-301; quiz 302-3. PubMed ID: 15678712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.